News

For many years, the rising complexity of APIs has led to the development of a sea of novel formulations that help in the efficient delivery of drugs to the intended site where action needs to happen. Nevertheless, the demand...

US Food and Drug Administration has come up with a novel draft guidance in order to further support the use of decentralised clinical trials when it comes to drugs, biologics, and devices. The publication has in it recommendations from...

One of the market reports has gone on to show that the digital biomanufacturing segment is expected to grow at a CAGR of 11% between 2023 and 2035 and will be driven largely by digital transformation. The influencing factors identified...

UCB, a global biopharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued positive opinions recommending granting marketing authorization for bimekizumab in the European Union (EU) for the...

Recipharm, a Global contract development and manufacturing organization (CDMO), has announced today that its subsidiary, GenIbet Biopharmaceuticals, has been approved by the US FDA as a manufacturing site of VOWST, a breakthrough orally administered fecal microbiota product for the...

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management (RBQM) Software for clinical trials, has launched registration for RBQM Live 2023, the foremost virtual event known for shaping the future of RBQM. This year, the free-to-attend...

When your optician or medical doctor informs you that you have the beginnings of the formation of a cataract, either in one eye or indeed both, it can sometimes come as a shock, especially if you currently have absolutely...